Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joincare Pharmaceutical Group Industry Co's quarterly Other Stockholders Equity
declined
from Sep. 2025 (¥1,823 Mil) to Dec. 2025 (¥1,284 Mil) but then
increased
from Dec. 2025 (¥1,284 Mil) to Mar. 2026 (¥1,964 Mil).
Joincare Pharmaceutical Group Industry Co's annual Other Stockholders Equity
increased
from Dec. 2023 (¥1,096 Mil) to Dec. 2024 (¥1,322 Mil) but then
declined
from Dec. 2024 (¥1,322 Mil) to Dec. 2025 (¥1,284 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joincare Pharmaceutical Group Industry Co Other Stockholders Equity Chart
Joincare Pharmaceutical Group Industry Co Annual Data
What does a Other Stockholders Equity of ¥1,964 Mil mean?
Joincare Pharmaceutical Group Industry Co (SHSE:600380) has a Other Stockholders Equity of ¥1,964 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors.
Is Joincare Pharmaceutical Group Industry Co's Other Stockholders Equity too high?
Joincare Pharmaceutical Group Industry Co's current Other Stockholders Equity is ¥1,964 Mil. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's Other Stockholders Equity compare to ZTS?
Joincare Pharmaceutical Group Industry Co's Other Stockholders Equity of ¥1,964 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. Joincare Pharmaceutical Group Industry Co's current Other Stockholders Equity is ¥1,964 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co (SHSE:600380) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥11.82, compared to a current price of ¥10.35 — trading 12.4% below its estimated fair value. The current Other Stockholders Equity is ¥1,964 Mil. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (SHSE:600380), the current Other Stockholders Equity is ¥1,964 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joincare Pharmaceutical Group Industry Co (SHSE:600380) Overvalued in 2026?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued.
The current stock price of ¥10.35 is trading 12.4% below its estimated GF Value™ of ¥11.82.
GuruFocus considers Joincare Pharmaceutical Group Industry Co to be Modestly Undervalued.
Key valuation signals for SHSE:600380:
Other Stockholders Equity: ¥1,964 Mil
GF Value™: ¥11.82 vs. price of ¥10.35 (12.4% below fair value)
No single metric tells the full story. See the SHSE:600380 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score
Get the complete analysis for SHSE:600380
Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600380 has been successfully added to your 
